Global Nano Biotechnology 麻豆原创 Research Report 2023

Publication ID:

PB503232713

Publication Date:

March 20, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Hardware (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

Highlights
The global Nano Biotechnology market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Nano Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Nano Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Nano Biotechnology in Pharmaceuticals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Nano Biotechnology include Aduro BioTech, Calando Pharmaceuticals, Biosante Phosphate Pharmaceuticals, Celgene Corporation, Elan Pharmaceuticals, Flamel Technologies, Nanophase Technologies, Sigma Aldrich Company and Dendritic Nanotechnologies, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nano Biotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nano Biotechnology.
The Nano Biotechnology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nano Biotechnology market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nano Biotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Aduro BioTech
Calando Pharmaceuticals
Biosante Phosphate Pharmaceuticals
Celgene Corporation
Elan Pharmaceuticals
Flamel Technologies
Nanophase Technologies
Sigma Aldrich Company
Dendritic Nanotechnologies
SkyePharma Pharmaceuticals
Segment by Type
0-10 nm
10-100 nm
Segment by Application
Pharmaceuticals
Medical Devices
Medical Research
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nano Biotechnology companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Nano Biotechnology 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 0-10 nm
1.2.3 10-100 nm
1.3 麻豆原创 by Application
1.3.1 Global Nano Biotechnology 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceuticals
1.3.3 Medical Devices
1.3.4 Medical Research
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nano Biotechnology 麻豆原创 Perspective (2018-2029)
2.2 Nano Biotechnology Growth Trends by Region
2.2.1 Global Nano Biotechnology 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nano Biotechnology Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Nano Biotechnology Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Nano Biotechnology 麻豆原创 Dynamics
2.3.1 Nano Biotechnology Industry Trends
2.3.2 Nano Biotechnology 麻豆原创 Drivers
2.3.3 Nano Biotechnology 麻豆原创 Challenges
2.3.4 Nano Biotechnology 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nano Biotechnology Players by Revenue
3.1.1 Global Top Nano Biotechnology Players by Revenue (2018-2023)
3.1.2 Global Nano Biotechnology Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Nano Biotechnology 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nano Biotechnology Revenue
3.4 Global Nano Biotechnology 麻豆原创 Concentration Ratio
3.4.1 Global Nano Biotechnology 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nano Biotechnology Revenue in 2022
3.5 Nano Biotechnology Key Players Head office and Area Served
3.6 Key Players Nano Biotechnology Product Solution and Service
3.7 Date of Enter into Nano Biotechnology 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Nano Biotechnology Breakdown Data by Type
4.1 Global Nano Biotechnology Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Nano Biotechnology Forecasted 麻豆原创 Size by Type (2024-2029)
5 Nano Biotechnology Breakdown Data by Application
5.1 Global Nano Biotechnology Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Nano Biotechnology Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Nano Biotechnology 麻豆原创 Size (2018-2029)
6.2 North America Nano Biotechnology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Nano Biotechnology 麻豆原创 Size by Country (2018-2023)
6.4 North America Nano Biotechnology 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nano Biotechnology 麻豆原创 Size (2018-2029)
7.2 Europe Nano Biotechnology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Nano Biotechnology 麻豆原创 Size by Country (2018-2023)
7.4 Europe Nano Biotechnology 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nano Biotechnology 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Nano Biotechnology 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Nano Biotechnology 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Nano Biotechnology 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nano Biotechnology 麻豆原创 Size (2018-2029)
9.2 Latin America Nano Biotechnology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Nano Biotechnology 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Nano Biotechnology 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nano Biotechnology 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Nano Biotechnology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Nano Biotechnology 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Nano Biotechnology 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aduro BioTech
11.1.1 Aduro BioTech Company Detail
11.1.2 Aduro BioTech Business Overview
11.1.3 Aduro BioTech Nano Biotechnology Introduction
11.1.4 Aduro BioTech Revenue in Nano Biotechnology Business (2018-2023)
11.1.5 Aduro BioTech Recent Development
11.2 Calando Pharmaceuticals
11.2.1 Calando Pharmaceuticals Company Detail
11.2.2 Calando Pharmaceuticals Business Overview
11.2.3 Calando Pharmaceuticals Nano Biotechnology Introduction
11.2.4 Calando Pharmaceuticals Revenue in Nano Biotechnology Business (2018-2023)
11.2.5 Calando Pharmaceuticals Recent Development
11.3 Biosante Phosphate Pharmaceuticals
11.3.1 Biosante Phosphate Pharmaceuticals Company Detail
11.3.2 Biosante Phosphate Pharmaceuticals Business Overview
11.3.3 Biosante Phosphate Pharmaceuticals Nano Biotechnology Introduction
11.3.4 Biosante Phosphate Pharmaceuticals Revenue in Nano Biotechnology Business (2018-2023)
11.3.5 Biosante Phosphate Pharmaceuticals Recent Development
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Detail
11.4.2 Celgene Corporation Business Overview
11.4.3 Celgene Corporation Nano Biotechnology Introduction
11.4.4 Celgene Corporation Revenue in Nano Biotechnology Business (2018-2023)
11.4.5 Celgene Corporation Recent Development
11.5 Elan Pharmaceuticals
11.5.1 Elan Pharmaceuticals Company Detail
11.5.2 Elan Pharmaceuticals Business Overview
11.5.3 Elan Pharmaceuticals Nano Biotechnology Introduction
11.5.4 Elan Pharmaceuticals Revenue in Nano Biotechnology Business (2018-2023)
11.5.5 Elan Pharmaceuticals Recent Development
11.6 Flamel Technologies
11.6.1 Flamel Technologies Company Detail
11.6.2 Flamel Technologies Business Overview
11.6.3 Flamel Technologies Nano Biotechnology Introduction
11.6.4 Flamel Technologies Revenue in Nano Biotechnology Business (2018-2023)
11.6.5 Flamel Technologies Recent Development
11.7 Nanophase Technologies
11.7.1 Nanophase Technologies Company Detail
11.7.2 Nanophase Technologies Business Overview
11.7.3 Nanophase Technologies Nano Biotechnology Introduction
11.7.4 Nanophase Technologies Revenue in Nano Biotechnology Business (2018-2023)
11.7.5 Nanophase Technologies Recent Development
11.8 Sigma Aldrich Company
11.8.1 Sigma Aldrich Company Company Detail
11.8.2 Sigma Aldrich Company Business Overview
11.8.3 Sigma Aldrich Company Nano Biotechnology Introduction
11.8.4 Sigma Aldrich Company Revenue in Nano Biotechnology Business (2018-2023)
11.8.5 Sigma Aldrich Company Recent Development
11.9 Dendritic Nanotechnologies
11.9.1 Dendritic Nanotechnologies Company Detail
11.9.2 Dendritic Nanotechnologies Business Overview
11.9.3 Dendritic Nanotechnologies Nano Biotechnology Introduction
11.9.4 Dendritic Nanotechnologies Revenue in Nano Biotechnology Business (2018-2023)
11.9.5 Dendritic Nanotechnologies Recent Development
11.10 SkyePharma Pharmaceuticals
11.10.1 SkyePharma Pharmaceuticals Company Detail
11.10.2 SkyePharma Pharmaceuticals Business Overview
11.10.3 SkyePharma Pharmaceuticals Nano Biotechnology Introduction
11.10.4 SkyePharma Pharmaceuticals Revenue in Nano Biotechnology Business (2018-2023)
11.10.5 SkyePharma Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Aduro BioTech
Calando Pharmaceuticals
Biosante Phosphate Pharmaceuticals
Celgene Corporation
Elan Pharmaceuticals
Flamel Technologies
Nanophase Technologies
Sigma Aldrich Company
Dendritic Nanotechnologies
SkyePharma Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.